India's Bold Leap: New Pharma Rules Set to Ignite R&D and Clinical Trials, Eyeing Global Leadership The Unseen Engine of Medicine: Small Molecule API Market Poised for Explosive Growth Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn? Trump's Trade Winds: Navigating the Storm for India's Pharma Giants